mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.045 |
0.4 |